A Study of Galcanezumab (LY2951742) in Adult Participants With Episodic Migraine
Clinical trial NCT05127486 · COMPLETED
Trial details
- NCT number
- NCT05127486
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-06
- Primary completion
- 2023-05-23
- Enrollment
- 580
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.